Journal
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Volume 32, Issue 4, Pages 391-394Publisher
CAMBRIDGE UNIV PRESS
DOI: 10.1086/659152
Keywords
-
Funding
- National Institutes of Health/National Institute of Allergy and Infectious Diseases [MK-K23AI083880]
Ask authors/readers for more resources
Recent surveillance from US hospitals shows that more than 99.5% of vancomycin-resistant enterococci (VRE) isolates remain susceptible to daptomycin. This report describes emergence of daptomycinresistant VRE at a major cancer center. The percentage of patients with daptomycin-resistant VRE bacteremia increased from 3.4% in 2007 to 15.2% in 2009 (Pp. 03). Without susceptibility data, empiric daptomycin therapy for VRE infections should be used with caution. Infect Control Hosp Epidemiol 2011;32(4):391-394
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
